Organization (Industry)
Gossamer Bio, Inc.
ClinicalTrials.gov lists Gossamer Bio, Inc. as lead sponsor of 11 trials, counting the companies grouped under it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section
21 sections measured, none recorded
This page covers Gossamer Bio, Inc. and 7 companies grouped under it: 11 lead-sponsored trials (0 its own, 11 in the grouped companies) and 2 legal-entity registrations (2 its own, 0 in the grouped companies).
Companies grouped under this page (7)
Shown in this order: most lead trials first.
| Company | Lead trials | Legal entities |
|---|---|---|
| GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 3 | 0 |
| GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc. | 2 | 0 |
| GB002, Inc. | 2 | 0 |
| GB004, Inc. | 1 | 0 |
| GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 1 | 0 |
Showing 5 of 7 member companies.
Financing and grant events (12)
Shown in this order: most recent first.
| Date | Round type | Amount (USD) | Source |
|---|---|---|---|
| 2026-01-28 | Other financing | not disclosed | Edgar offerings |
| 2023-08-28 | Other financing | not disclosed | Edgar offerings |
| 2023-08-17 | Other financing | not disclosed | Edgar offerings |
| 2023-07-24 | Private placement | 212,102,057 | Form d |
| 2022-08-09 | Other financing | not disclosed | Edgar offerings |
Showing 5 of 12 events.
Latest dated events (12)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-01-28 | Financing | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2023-08-28 | Financing | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2023-08-17 | Financing | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2023-07-24 | Private placement | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2022-08-09 | Financing | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
Showing 5 of 12 events.
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, disease areas, trials by start year as sponsor or collaborator, active development programs, approved assets, sponsor delivery record, journals published in, us granted patents, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.